2m 2m 2m 2m 2m 2m 2m
KINIKSA PHARMA (KNSA)
NASDAQ
$81.20+$0.41 (+0.50%)
Price as of Oct 23, 2026 5:53 AM EDT- $3.4BMarket Cap
- 108.38%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
KINIKSA PHARMA (KNSA)
$81.20+$0.41 (+0.50%)
KNSA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $80.79 | ||
Change | +$1.09 (+1.37%) | ||
Open | $79.32 | ||
High | $81.30 | ||
Low | $78.39 | ||
Previous Close | $79.70 | ||
Volume | 429,696 | ||
30-Day Average Volume | 590,906 | ||
1-Week Change | 1.06% | ||
1-Month Change | 3.58% | ||
1-Year Change | 108.38% | ||
3-Year Change | 418.88% | ||
5-Year Change | 653.64% | ||
Fundamentals | |||
Shares Outstanding | 42.0M | ||
Total Assets | $896.1M | ||
Market Cap | $3.4B | ||
Enterprise Value | $3.2B | ||
Period: QTR TTM FY | |||
Revenue | $243.6M | ||
Net Income | $25.4M | ||
Free Cash Flow | $46.5M | ||
EBIT | $31.1M | ||
EBITDA | $31.6M | ||
Net Working Capital | $497.4M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | 102 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 5 | ||
P/E | 269 | ||
PEG | 24 | ||
Price/Free Cash Flow | 73 | ||
Price/Operating Cash Flow | 72 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue